|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy of gonadotropin -releasing hormone agonist and an extended -interval dosing regimen inthe treat- ment of patients with adenomyosis and endometriosis 显示文摘 | Kang JL Wang XX Nie ML | 2010 | Gynecologic and Obstetric Investigation2010，69，2： | 1 |
| 2 | Efficacy of gonadotropin-releas- ing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometfiosis 显示文摘 | Kang JL Wang XX Nie ML | 2010 | Gynecol Obstet Invest2010，69，2： | 1 |
| 3 | Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2 显示文摘 | Fu YC Nie H Ho ML | 2008 | Biotechnol Bioeng2008，99，4： | 1 |
| 4 | Efficacy of gonadotropin-releas- ing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis 显示文摘 | Kang JL Wang XX Nie ML | 2010 | Gynecol Obstet Invest2010，69，2： | 1 |
| 5 | Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2显示文摘 | Fu YC Nie H Ho ML | 2008 | Biotechnol Bioeng2008，99，4： | 1 |
| 6 | Efficacy of gonadotropin - relea-sing hormone agonist and an extended - interval dosing regimen inthe treatment of patients with adenomyosis and endometriosis 显示文摘 | Kang JL Wang XX Nie ML | 2010 | Gynecol Obstet Invest2010，69，2： | 1 |
| 7 | BMP-2 plasmidloaded PLGA/HAp composite scaffolds for treatment of bonedefects in nude mice显示文摘 | Nie H Ho ML Wang CK Wang CH Fu YC | 2009 | Biomaterials2009，30，5： | 1 |
| 8 | BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice显示文摘 | Nie H Ho ML Wang CK | | 0，，05： | 1 |
| 9 | Avenanthramide,a polyphenol from oats,inhibits vascular smooth muscle cell proliferation and enhanees nitric oxide production显示文摘 | Nie L Wise ML Peterson DM | 2006 | Atherosclerosis2006，186，2： | 1 |
| 10 | Efficacy of gonadotropin-re- leasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis 显示文摘 | Kang JL Wang XX Nie ML | 2010 | Gynecol Obstet Invest2010，69，2： | 1 |
| 11 | BMP-2 plasmid loaded PLGA/ HAp composite scaffolds for treatment of bone defects in nude mice 显示文摘 | Nie H Ho ML Wang CK | 2009 | Biomaterials2009，30，5： | 1 |
| 12 | BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice显示文摘 | NIE HM HO ML WANG CK | 2009 | Biomaterials2009，30，： | 1 |
| 13 | Avenan-thramide,a polyphenol from oats,inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production显示文摘 | Nie L Wise ML Peterson DM | 2006 | Atherosclerosis2006，186，2： | 1 |
| 14 | Avenanthramide, a polyphenol from oats, inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production 显示文摘 | Nie L Wise ML Petemon DM | 2006 | Athemsclerosis2006，186，2： | 1 |
| 15 | Optimized bone regeneration based on sustained release from three - dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP - 2 显示文摘 | Fu YC Nie H Ho ML | 2008 | Biotechnol Bioeng2008，99，4： | 1 |
| 16 | Optimized bone regenera- tion based on sustained release from three-dimensional fibrous PLGA / HAp composite scaffolds loaded withBMP-2 显示文摘 | Fu YC Nie H Ho ML | 2008 | Biotechnol Bioeng2008，99，4： | 1 |
| 17 | Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis 显示文摘 | Kang JL Wang XX Nie ML | 2010 | Gynecol Obstet Invest2010，69，2： | 1 |
| 18 | Avenanthramide, a polyphenol from oats, inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production 显示文摘 | NIE L WISE ML PETERSON DM | 2006 | Atheroselerosis2006，186，2： | 1 |
| 19 | Efficacy of gonadotro- phin-releasing hormone agonist and an extended-interval do- sing regimen in the treatment of patients with adenomyosis and endometriosis 显示文摘 | Kang JL Wang XX Nie ML | 2010 | Gynecol Obstet Invest2010，69，2： | 1 |
| 20 | Avenanthramide, a poly- phenol from oats, inhibits vascular smooth muscle cell prolifer- ation and enhances nitric oxide production显示文摘 | Nie L Wise ML Peterson DM | 2006 | Atherosclerosis2006，186，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员